StoneCrest Wealth Management »

Regeneron Pharmaceuticals shares owned by StoneCrest Wealth Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by StoneCrest Wealth Management from 13F filings

Historical chart of StoneCrest Wealth Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by StoneCrest Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by StoneCrest Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $309k 321 962.49
2023-12-31 $285k 325 878.29

More positions owned by StoneCrest Wealth Management

Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
NVIDIA Corporation (NVDA)
Vaneck Etf Trust Semiconductr Etf (SMH)
First Tr Nas100 Eq Weighted SHS (QQEW)
First Tr Exchange Traded Nasdaq Cyb Etf (CIBR)
J P Morgan Exchange Traded F Nasdaq Eqt Prem (JEPQ)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Global X Fds S&p 500 Covered (XYLD)
Apple (AAPL)
Wisdomtree Tr Cloud Computng (WCLD)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for StoneCrest Wealth Management

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Geode Capital Management
Dodge & Cox
Franklin Resources
Loomis, Sayles and
Wellington Management Company
Northern Trust
Legal & General Group
Bank of America Corporation
Amundi
Bank of New York Mellon
American Century Companies

View all funds holding Regeneron Pharmaceuticals